Cargando…

Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer

Vascular endothelial growth factor (VEGF)‐A is known to play an important role in tumor angiogenesis. Three additional members of the VEGF family, VEGF‐B, ‐C and ‐D, have recently been discovered. VEGF‐C and VEGF‐D are ligands for VEGF receptor‐3, which is expressed in the endothelium of lymphatic v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurebayashi, Junichi, Otsuki, Takemi, Kunisue, Hironori, Mikami, Yoshinori, Tanaka, Katsuhiko, Yamamoto, Shigeru, Sonoo, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1999
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926164/ https://www.ncbi.nlm.nih.gov/pubmed/10551327 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00844.x

Ejemplares similares

A Radicicol Derivative, KF58333, Inhibits Expression of Hypoxia‐inducible Factor‐1α and Vascular Endothelial Growth Factor, Angiogenesis and Growth of Human Breast Cancer Xenografts
por: Kurebayashi, Junichi, et al.
Publicado: (2001)

Hypoxia Reduces Hormone Responsiveness of Human Breast Cancer Cells
por: Kurebayashi, Junichi, et al.
Publicado: (2001)

Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
por: Kunisue, H, et al.
Publicado: (2000)

Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect
por: Kurebayashi, J, et al.
Publicado: (1999)

Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells
por: Okubo, S, et al.
Publicado: (2004)

Analysis of Clinical Outcome of Patients with Poorly Differentiated Thyroid Carcinoma
por: Tanaka, Katsuhiro, et al.
Publicado: (2011)

Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype
por: Kurebayashi, Junichi, et al.
Publicado: (2010)

The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease
por: Holmes, David IR, et al.
Publicado: (2005)

Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
por: Kurebayashi, J, et al.
Publicado: (1999)

The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure
por: Namisaki, Tadashi, et al.
Publicado: (2010)

Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells.
por: Kurebayashi, J., et al.
Publicado: (1997)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Endothelial Progenitor Cells Promote Directional Three-Dimensional Endothelial Network Formation by Secreting Vascular Endothelial Growth Factor
por: Abe, Yoshinori, et al.
Publicado: (2013)

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
por: Yamamoto, S., et al.
Publicado: (1997)

Expression of vascular endothelial growth factor (VEGF) in equine sarcoid
por: Martano, Manuela, et al.
Publicado: (2018)

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
por: Barratt, Shaney L., et al.
Publicado: (2018)

A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice.
por: Kurebayashi, J., et al.
Publicado: (1995)

A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice.
por: Kurebayashi, J., et al.
Publicado: (1996)

Expression of Vascular Endothelial Growth Factor (VEGF) Associated with Histopathological Changes in Rodent Models of Osteoarthritis
por: Yamairi, Fumiko, et al.
Publicado: (2011)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF
por: Man, Xiao-Yong, et al.
Publicado: (2008)

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
por: Schmidinger, Manuela
Publicado: (2013)

Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy
por: Lin, Shuhua, et al.
Publicado: (2016)

Downregulation of Fes inhibits VEGF-A-induced chemotaxis and capillary-like morphogenesis by cultured endothelial cells
por: Kanda, Shigeru, et al.
Publicado: (2007)

The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer
por: Goulart, André, et al.
Publicado: (2019)

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
por: Rennel, E S, et al.
Publicado: (2009)

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
por: Banks, R. E., et al.
Publicado: (1998)

Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value
por: Herrlinger, U, et al.
Publicado: (2004)

Multiscale modeling of tumor response to vascular endothelial growth factor (VEGF) inhibitor
por: Hendrata, Melisa, et al.
Publicado: (2022)

Modeling the Cluster Size Distribution of Vascular Endothelial Growth Factor (VEGF) Receptors
por: Güven, Emine, et al.
Publicado: (2022)

Heparin-Induced Changes of Vascular Endothelial Growth Factor (VEGF(165)) Structure
por: Nemashkalova, Ekaterina L., et al.
Publicado: (2023)

Expression and correlation analysis of RegIV and vascular endothelial growth factors (VEGF-A and VEGF-C) in metastatic spinal tumors
por: Zhang, Shuquan, et al.
Publicado: (2017)

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.
por: Obermair, A., et al.
Publicado: (1998)

Interactions between Endostatin and Vascular Endothelial Growth Factor (VEGF) and Inhibition of Choroidal Neovascularization
por: Wang, Xun, et al.
Publicado: (2007)

Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease
por: Wieck, Minna M., et al.
Publicado: (2016)

VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43
por: Li, Lufeng, et al.
Publicado: (2017)

The Effect and Mechanism of Vascular Endothelial Growth Factor (VEGF) on Tumor Angiogenesis in Gallbladder Carcinoma
por: XU, Dongqing, et al.
Publicado: (2019)

Automated and Reproducible Detection of Vascular Endothelial Growth Factor (VEGF) in Renal Tissue Sections
por: Macedo, Nayana Damiani, et al.
Publicado: (2019)

Islet vascularization is regulated by primary endothelial cilia via VEGF-A-dependent signaling
por: Xiong, Yan, et al.
Publicado: (2020)

Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4rpmq7sgi5t32lc25d40nq9nlq